BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38001886)

  • 1. Active Matrix Metalloproteinase-8 (aMMP-8) Versus Total MMP-8 in Periodontal and Peri-Implant Disease Point-of-Care Diagnostics.
    Räisänen IT; Aji NRAS; Sakellari D; Grigoriadis A; Rantala I; Pätilä T; Heikkilä P; Gupta S; Sorsa T
    Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic.
    Sorsa T; Sahni V; Buduneli N; Gupta S; Räisänen IT; Golub LM; Lee HM; Pätilä T; Bostanci N; Meurman J; Pärnänen P; Nwhator SO; Singla M; Gauba K
    Expert Rev Proteomics; 2021 Aug; 18(8):707-717. PubMed ID: 34468272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active MMP-8 point-of-care (PoC)/chairside enzyme-test as an adjunctive tool for early and real-time diagnosis of peri-implantitis.
    Lähteenmäki H; Tervahartiala T; Räisänen IT; Pärnänen P; Mauramo M; Gupta S; Sampson V; Rathnayake N; Heikkinen AM; Alassiri S; Gieselmann DR; Frankenberger R; Sorsa T
    Clin Exp Dent Res; 2022 Apr; 8(2):485-496. PubMed ID: 35118828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. aMMP-8 point-of-care - diagnostic methods and treatment modalities in periodontitis and peri-implantitis.
    Lähteenmäki H; Pätilä T; Pärnänen CP; Räisänen I; Tervahartiala T; Gupta S; Sorsa T
    Expert Opin Ther Targets; 2023; 27(7):627-637. PubMed ID: 37522314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix Metalloproteinase-8 as an Inflammatory and Prevention Biomarker in Periodontal and Peri-Implant Diseases.
    Al-Majid A; Alassiri S; Rathnayake N; Tervahartiala T; Gieselmann DR; Sorsa T
    Int J Dent; 2018; 2018():7891323. PubMed ID: 30305812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. aMMP-8 Point-of-Care/Chairside Oral Fluid Technology as a Rapid, Non-Invasive Tool for Periodontitis and Peri-Implantitis Screening in a Medical Care Setting.
    Lähteenmäki H; Umeizudike KA; Heikkinen AM; Räisänen IT; Rathnayake N; Johannsen G; Tervahartiala T; Nwhator SO; Sorsa T
    Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32764436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases.
    Sorsa T; Nwhator SO; Sakellari D; Grigoriadis A; Umeizudike KA; Brandt E; Keskin M; Tervahartiala T; Pärnänen P; Gupta S; Mohindra R; Bostanci N; Buduneli N; Räisänen IT
    Front Oral Health; 2022; 3():897115. PubMed ID: 35757444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of aMMP-8 and azurocidin in peri-implant sulcular fluid as biomarkers of peri-implant health or disease.
    Xanthopoulou V; Räisänen IT; Sorsa T; Tortopidis D; Sakellari D
    Clin Exp Dent Res; 2024 Jun; 10(3):e883. PubMed ID: 38853451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ability of Quantitative, Specific, and Sensitive Point-of-Care/Chair-Side Oral Fluid Immunotests for aMMP-8 to Detect Periodontal and Peri-Implant Diseases.
    Alassiri S; Parnanen P; Rathnayake N; Johannsen G; Heikkinen AM; Lazzara R; van der Schoor P; van der Schoor JG; Tervahartiala T; Gieselmann D; Sorsa T
    Dis Markers; 2018; 2018():1306396. PubMed ID: 30154936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary Diagnostics-Point-of-Care diagnostics of MMP-8 in dentistry and medicine.
    Rathnayake N; Gieselmann DR; Heikkinen AM; Tervahartiala T; Sorsa T
    Diagnostics (Basel); 2017 Jan; 7(1):. PubMed ID: 28117682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a noninvasive aMMP-8 point-of-care diagnostic methodology in COVID-19 patients with periodontal disease.
    Gupta S; Mohindra R; Singla M; Khera S; Kumar A; Rathnayake N; Sorsa T; Pfützner A; Räisänen IT; Soni RK; Kanta P; Jain A; Gauba K; Goyal K; Singh MP; Ghosh A; Kajal K; Mahajan V; Suri V; Bhalla A
    Clin Exp Dent Res; 2022 Aug; 8(4):988-1001. PubMed ID: 35818743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active MMP-8 as a Biomarker of Peri-implant Health or Disease.
    Xanthopoulou V; Räisänen I; Sorsa T; Sakellari D
    Eur J Dent; 2023 Jul; 17(3):924-928. PubMed ID: 36063841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active MMP-8 (aMMP-8) as a Grading and Staging Biomarker in the Periodontitis Classification.
    Sorsa T; Alassiri S; Grigoriadis A; Räisänen IT; Pärnänen P; Nwhator SO; Gieselmann DR; Sakellari D
    Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 31979091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of active matrix metalloproteinase-8 (aMMP-8) chair-side test as a diagnostic biomarker in the staging of periodontal diseases.
    Öztürk VÖ; Emingil G; Umeizudike K; Tervahartiala T; Gieselmann DR; Maier K; Köse T; Sorsa T; Alassiri S
    Arch Oral Biol; 2021 Apr; 124():104955. PubMed ID: 33556789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of collagenase-2 from gingival crevicular fluid and peri-implant sulcular fluid in periodontitis and peri-implantitis patients: pilot study.
    Xu L; Yu Z; Lee HM; Wolff MS; Golub LM; Sorsa T; Kuula H
    Acta Odontol Scand; 2008 Aug; 66(4):219-24. PubMed ID: 18615324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of active matrix metalloproteinase-8 point-of-care test for the discrimination of periodontal health status: Comparison of saliva and oral rinse samples.
    Deng K; Wei S; Xu M; Shi J; Lai H; Tonetti MS
    J Periodontal Res; 2022 Aug; 57(4):768-779. PubMed ID: 35575900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-8 levels in oral samples as a biomarker for periodontitis in the Chinese population: an observational study.
    Yuan C; Liu X; Zheng S
    BMC Oral Health; 2018 Mar; 18(1):51. PubMed ID: 29587716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of gingival crevicular fluid matrix metalloproteinase-8 provides site-specific diagnostic value for periodontal grading.
    Nędzi-Góra M; Górska R; Górski B
    Cent Eur J Immunol; 2021; 46(2):236-243. PubMed ID: 34764793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines.
    Sorsa T; Tervahartiala T; Leppilahti J; Hernandez M; Gamonal J; Tuomainen AM; Lauhio A; Pussinen PJ; Mäntylä P
    Pharmacol Res; 2011 Feb; 63(2):108-13. PubMed ID: 20937384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Metalloproteinase-8 Levels in Crevicular Fluid of Patients with Healthy Implants or Periodontitis.
    Aleksandrowicz P; Żelechowska P; Agier J; Starska K; Kędzierski K; Wysokińska-Miszczuk J; Brzezińska-Błaszczyk E
    Mediators Inflamm; 2017; 2017():4920847. PubMed ID: 28757684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.